The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1619
ISSUE 1619
March 8, 2021
Sodium Sulfate-Based Tablets (Sutab) for Colonoscopy Preparation
| Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
March 8, 2021 (Issue: 1619)
The FDA has approved an oral tablet formulation of
sodium sulfate, magnesium sulfate, and potassium
chloride (Sutab – Braintree) for colon cleansing prior
to colonoscopy in adults. A sodium sulfate-based oral
solution (Suprep) has been available in the US since
2010. Sutab is the second tablet formulation to be
approved for bowel cleansing prior to colonoscopy;
a sodium phosphate-based tablet (OsmoPrep) was
approved earlier.
... more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Purchase this article:
Title: Sodium Sulfate-Based Tablets (Sutab) for Colonoscopy Preparation
Article code: 1619a
Electronic, downloadable article - $45
Article code: 1619a
Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian
